Klail, Tomas http://orcid.org/0000-0002-8749-6066
Kurmann, Christoph
Kaesmacher, Johannes
Mujanovic, Adnan
Piechowiak, Eike I.
Dobrocky, Tomas
Pilgram-Pastor, Sara
Scutelnic, Adrian
Heldner, Mirjam R.
Gralla, Jan
Mordasini, Pasquale
Funding for this research was provided by:
University of Bern
Article History
Received: 18 May 2022
Accepted: 30 July 2022
First Online: 7 September 2022
Declarations
:
: J. Kaesmacher reports grants from the Swiss Academy of Medical Sciences/Bangerter Foundation, Swiss Stroke Society, and Clinical Trials Unit Bern during the conduct of the study. A. Scutelnic reports research support from Swiss Heart Foundation, not related to this manuscript. M.R. Heldner reports grants from the Swiss National Science Foundation, the Swiss Heart Foundation, the SITEM Support Funds and from the Bangerter Foundation, and Advisory Board participation for Amgen, unrelated to the submitted work. J. Gralla is the global co-principal investigator of the SWIFT DIRECT trial (Solitaire With the Intention for Thrombectomy Plus Intravenous tPA Versus DIRECT Solitaire Stent-Retriever Thrombectomy in Acute Anterior Circulation Stroke; Medtronic), therefore consultant Medtronic. He receives Swiss National Science Foundation grants for magnetic resonance imaging in stroke. P. Mordasini reports research support from Siemens, Cerenovus, iSchemaview, Medtronic and Stryker, and receipt of honoraria and consultation fees from Medtronic, Cerenovus, Phenox and Microvention payed to the institution. T. Klail, C. Kurmann, A. Mujanovic, E.I. Piechowiak, T. Dobrocky, S. Pilgram-Pastor and A. Scutelnic declare that they have no competing interests.
: The study was approved by the local ethics committee (Kantonale Ethikkommission für die Forschung Bern, Bern Switzerland, amendment access number: 231/2014).